Plus, AMC shares are down as movie theaters close with no big releases until the end of this year, Bristol-Myers Squibb is buying MyoKardia, and Nvidia is building a $52 million supercomputer for Cambridge.
Read MorePlus, nonfarm payrolls for September came in lower than expected, stimulus talks are in limbo, and Tesla delivered more vehicles than expected in the third quarter.
Read MorePlus, initial jobless claims were lower than expected, AstraZeneca shares are down after the FDA said it’s expanding its inquiry into the serious illness of a participant in its COVID vaccine trial, and the CEOs of Facebook, Google, and Twitter will be subpoenaed for testimony by the Senate Commerce Committee.
Read MorePlus, several blue-chip companies announced tens of thousands of job cuts, Moderna and Regeneron are up on positive coronavirus drug news, and two software companies went public through direct listings this morning.
Read MorePlus, global coronavirus cases surpassed 1 million, JPMorgan will pay $920 million to resolve probes related to ‘spoofing’ by its traders, and Nikola shares are down again this morning on assault allegations against former Chairman Milton.
Read MorePlus, Goldman Sachs said fears that a delayed U.S. election result could upend the stock market are overblown, Novavax entered a late stage trial for its coronavirus vaccine candidate, and Amazon announced two new Fire TV sticks.
Read MorePlus, President Trump refused to commit to a peaceful transition of power should he lose the November election, last week’s initial jobless claims were higher than expected, and United Airlines is about to start offering rapid coronavirus tests to some fliers to Hawaii.
Read MoreThrough the summer, one of the best sectors of the stock market’s rally back to, and even above pre-pandemic levels has been the Materials sector. Beginning in mid-May to the end of the last week, the sector had increased in value by more than 71% as measured by the S&P 500 Materials Sector SPDR (XLB). […]
Read MorePlus, jobless claims were lower than expected for last week though recovery in the labor market appears to be slowing, there’s a glimmer of hope on the stimulus front, and Moderna said it should have data for its late-stage coronavirus vaccine trial in November.
Read MorePlus, the Fed wraps up its last meeting before the presidential election today, U.S. consumer spending slowed in August, and Eli Lilly said its antibody treatment for the coronavirus appeared to reduce hospitalization rates in a trial.
Read MorePlus, Nikola shares are down following reports that the SEC is investigating a short-seller’s fraud claims, and Apple shares are up ahead of its first major product launch event of 2020.
Read MorePlus, weekly jobless claims were higher than expected, AstraZeneca said it still expects to know whether its coronavirus vaccine will be safe and effective before the end of this year, and LVMH is suing Tiffany.
Read MorePlus, the unemployment rate fell to 8.4% in August, the WHO said it doesn’t expect the world will see large-scale coronavirus vaccinations until mid-2021, and Peloton announced a new lower-priced treadmill and a new premium bike model.
Read MorePlus, new weekly jobless claims totaled 881,000, Pfizer said it could have results from its Phase 3 coronavirus vaccine trial as early as October, and Tesla has fallen to near bear market territory.
Read MorePlus, ADP said private payrolls grew by just 428,000 in August, and Macy’s shares are up even after posting a loss as online sales jump 53% in its most recent quarter.
Read More